About half of the bi-transgenic mice examined (n = 23) developed palpable mammary tumors by the age of 19 weeks (T1/2 = 19), whereas fewer than 30% of the Wnt1 transgenic and none of the ILK or FVB control mice had tumors. This evidence concerns the gene WNT1 and breast cancer.